REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Hyundai Pharmaceutical Co.,Ltd (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hyundai Pharmaceutical Co.,Ltd Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Hyundai Pharmaceutical Co., Ltd is a pharmaceutical company that focuses on discovery research technologies and original drug development. It aims to make significant scientific contributions and be a recognized performance leader in the domestic market.

Headquarters
200 Namkwan-Ri, Poongse-Myeon, Cheonahn-Si
Cheonan; Chungcheongnam; Postal Code: 330-911

Contact Details: Purchase the Hyundai Pharmaceutical Co.,Ltd report to view the information.

Website: http://www.hyundaipharm.co.kr

Basic Information
Total Employees:
Purchase the Hyundai Pharmaceutical Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Hyundai Pharmaceutical Co.,Ltd report to view the information.
Registered Capital:
Purchase the Hyundai Pharmaceutical Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Hyundai Pharmaceutical Co.,Ltd report to view the information.
Incorporation Date:
July 16, 1965
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
President
Purchase this report to view the information.
Chief Technology Officer
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
19.78%
Purchase this report to view the information.
3.52%
Purchase this report to view the information.
2.26%
Purchase this report to view the information.
0.84%
Purchase this report to view the information.
0.34%
Subsidiaries
A & Pep
80%
Hyundai Natural
15%
Biobud
6.2%
Company Performance
Financial values in the chart are available after Hyundai Pharmaceutical Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
11.11%▲
Total operating revenue
19.69%▲
Operating profit (EBIT)
2.18%▲
EBITDA
114.74%▲
Net Profit (Loss) for the Period
N/A
Total assets
-14.64%▼
Total equity
-2.19%▼
Operating Profit Margin (ROS)
-0.39%▼
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
1.15%▲
Quick Ratio
-0.07%▼
Cash Ratio
-0.13%▼

Similar companies

Cj Cheiljedang Corporation
 
SK Discovery Co.,Ltd.
Kt&G Corporation
 
Amore Pacific Group
Samsung Biologics Co., Ltd.
 
Green Cross Holdings Corporation
Samchundang Pharm. Co.,Ltd.
 
Samil Pharm. Co.,Ltd.
Gc Cell Corporation
 
Myungmoon Pharm. Co.,Ltd.
Korea Arlico Pharm Co.,Ltd.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo